SkinDermic is a spinoff of Paris Descartes, Sorbonne Université, INSERM and APHP (Assistance Publique Hopitaux de Paris).
These partners have promoted the creation and the development of SkinDermic as a new and innovative Bio-Pharma company. All the research programs that allowed to discover innovative new drugs own by SkinDermic were conducted in these institutions.
In partnership with the city of Paris and Bpifrance, SkinDermic has established a convention “Paris Innovation Priming” (PIA) and obtained a grant of 45 k€ first quarter 2019.